Quanterix Corporation Deferred Revenue, Revenue Recognized
Quanterix Corporation (QTRX) reported Deferred Revenue, Revenue Recognized of $2.50 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2025-05-12
- Quanterix Corporation deferred revenue, revenue recognized for the quarter ending 2025-03-31 was $2.50M, a 7.41% decline year-over-year.
- Quanterix Corporation deferred revenue, revenue recognized for the quarter ending 2024-03-31 was $2.70M, a 12.50% increase year-over-year.
- Quanterix Corporation deferred revenue, revenue recognized for the quarter ending 2023-03-31 was $2.40M.
- Quanterix Corporation deferred revenue, revenue recognized for fiscal 2024 was $7.90M, a 2.60% increase from fiscal 2023.
- Quanterix Corporation deferred revenue, revenue recognized for fiscal 2023 was $7.70M, a 40.00% increase from fiscal 2022.
- Quanterix Corporation deferred revenue, revenue recognized for fiscal 2022 was $5.50M.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 9 month | Deferred Revenue, Revenue Recognized 12 month | Deferred Revenue, Revenue Recognized 12 month as first filed |
|---|---|---|---|---|---|
| 2025-03-31 | $2.50M 10-Q · filed 2025-05-12 | ||||
| 2024-12-31 | $7.90M 10-K · filed 2025-03-17 | ||||
| 2024-03-31 | $2.70M 10-Q · filed 2025-05-12 | ||||
| 2023-12-31 | $7.70M 10-K · filed 2025-03-17 | ||||
| 2023-09-30 | $6.40M 10-Q · filed 2023-11-08 | ||||
| 2023-06-30 | $4.90M 10-Q · filed 2023-08-08 | ||||
| 2023-03-31 | $2.40M 10-Q/A · filed 2024-12-26 | ||||
| 2022-12-31 | $5.50M 10-K/A · filed 2024-12-26 | $3.60M 10-Q · filed 2023-08-08 | |||
| 2022-09-30 | $4.70M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |